Dravet syndrome

Cannabis-derived epilepsy drug on the horizonA pharmaceutical formulation of purified cannabidiol, a cannabinoid without euphoric side effects, is expected to launch in the second half of this year.
Two potential drugs to treat Dravet syndromePhase III clinical trials of new antiepileptic medications show promise for reducing frequency of convulsive seizures in children.
FDA drug approvals-February 2015FDA actions in brief, priority review, breakthrough designations, orphan drug designations